Interfacebiologics: Interface Biologics Inc.: Interface Biologics Announces Spinout, Ripple Therapeutics

TORONTO, ON / ACCESSWIRE / January 14, 2020 / Following the sale of its surface modification business to Evonik (EVR:ETK), Interface Biologics Inc. ("IBI"), is pleased to announce the launch of Rip...